Important Safety Information |
Prescribing Information | |
![]() |
Patients taking Viramune® (nevirapine) may develop severe liver disease or skin reactions that can cause death. The risk of these reactions is greatest during the first 18 weeks of treatment, but these reactions also can occur later.
Liver Reactions Patients starting VIRAMUNE with abnormal liver function tests and patients with hepatitis B or C have a greater chance of developing further increases in liver function tests after starting VIRAMUNE and throughout therapy. In rare cases liver problems have led to liver failure and can lead to a liver transplant or death. Therefore, if you develop any of the following symptoms of liver problems stop taking VIRAMUNE and call your doctor right away:
Your doctor should check you and do blood tests often to check your liver function during the first 18 weeks of therapy. Checks for liver problems should continue regularly during treatment with VIRAMUNE.
Skin Reactions
If your doctor tells you to stop treatment with VIRAMUNE because you have experienced the serious liver or skin reactions described above, never take VIRAMUNE again. These are not all the side effects of VIRAMUNE. (See the section "What are the possible side effects of VIRAMUNE?" in the Medication Guide for more information.) Tell your doctor if you have any side effects from VIRAMUNE. |
|
![]() |
||
| Please read Medication Guide and Important Safety Information before taking VIRAMUNE. (Adobe® Acrobat® required.) |
This site is intended for U.S. residents only. |
|
| Copyright © 2006, Boehringer Ingelheim Pharmaceuticals, Inc. VR10798 | ||